Numeric Investors LLC - ENANTA PHARMACEUTICALS INC ownership

ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 127 filers reported holding ENANTA PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 0.30 and the average weighting 0.3%.

Quarter-by-quarter ownership
Numeric Investors LLC ownership history of ENANTA PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2017$14,608,000
+80.8%
248,942
+44.2%
0.11%
+71.0%
Q3 2017$8,078,000
+193.1%
172,602
+125.3%
0.06%
+158.3%
Q2 2017$2,756,000
+13.0%
76,602
-3.3%
0.02%
+9.1%
Q1 2017$2,439,000
-33.1%
79,200
-27.2%
0.02%
-33.3%
Q4 2016$3,645,000
-8.6%
108,800
-27.4%
0.03%
-13.2%
Q3 2016$3,989,000
+1252.2%
149,900
+1018.7%
0.04%
+1166.7%
Q2 2016$295,000
-88.6%
13,400
-84.8%
0.00%
-88.9%
Q1 2016$2,589,000
+120.5%
88,144
+171.4%
0.03%
+92.9%
Q3 2015$1,174,000
-88.9%
32,481
-86.2%
0.01%
-88.5%
Q2 2015$10,599,000
+5121.2%
235,581
+5789.5%
0.12%
+3966.7%
Q4 2014$203,000
-95.4%
4,000
-96.4%
0.00%
-95.4%
Q3 2014$4,400,000
+801.6%
111,200
+811.5%
0.06%
+712.5%
Q1 2014$488,000
-55.1%
12,200
-69.3%
0.01%
-55.6%
Q4 2013$1,086,00039,8000.02%
Other shareholders
ENANTA PHARMACEUTICALS INC shareholders Q3 2017
NameSharesValueWeighting ↓
Krensavage Asset Management, LLC 862,848$42,556,00014.73%
Fairmount Funds Management LLC 171,147$8,441,0003.56%
ARMISTICE CAPITAL, LLC 1,648,000$81,279,0001.87%
FARALLON CAPITAL MANAGEMENT LLC 1,995,000$98,393,0000.49%
Jackson Creek Investment Advisors LLC 21,409$1,056,0000.37%
Hennion & Walsh Asset Management, Inc. 113,940$5,620,0000.34%
Virtus ETF Advisers LLC 14,721$726,0000.31%
Granahan Investment Management 193,416$9,539,0000.20%
Yorktown Management & Research Co Inc 4,500$222,0000.18%
JACOBS LEVY EQUITY MANAGEMENT, INC 242,257$11,948,0000.09%
View complete list of ENANTA PHARMACEUTICALS INC shareholders